The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies
View ORCID ProfileJD Ward, C Cornaby, T Kato, RC Gilmore, D Bunch, MB Miller, RC Boucher, JL Schmitz, FA Askin, LR Scanga
doi: https://doi.org/10.1101/2022.02.01.22270179
JD Ward
aUniversity of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, USA
C Cornaby
bImmunology, Histocompatibility and Immunogenetics Laboratories/McLendon Clinical Laboratories UNC Hospitals, Chapel Hill, North Carolina, USA
T Kato
cUniversity of North Carolina School of Medicine, Marisco Lung Institute/UNC Cystic Fibrosis Center, Chapel Hill, North Carolina, USA
RC Gilmore
cUniversity of North Carolina School of Medicine, Marisco Lung Institute/UNC Cystic Fibrosis Center, Chapel Hill, North Carolina, USA
D Bunch
dUniversity of North Carolina School of Medicine, Department of Medicine, Division of Nephrology and Hypertension, Chapel Hill, North Carolina, USA
MB Miller
aUniversity of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, USA
eClinical Microbiology and Molecular Microbiology Laboratories, University of North Carolina Health Care, Chapel Hill, North Carolina, USA
RC Boucher
cUniversity of North Carolina School of Medicine, Marisco Lung Institute/UNC Cystic Fibrosis Center, Chapel Hill, North Carolina, USA
JL Schmitz
aUniversity of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, USA
bImmunology, Histocompatibility and Immunogenetics Laboratories/McLendon Clinical Laboratories UNC Hospitals, Chapel Hill, North Carolina, USA
FA Askin
aUniversity of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, USA
LR Scanga
aUniversity of North Carolina School of Medicine, Department of Pathology and Laboratory Medicine, Chapel Hill, North Carolina, USA
Article usage
Posted February 02, 2022.
The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies
JD Ward, C Cornaby, T Kato, RC Gilmore, D Bunch, MB Miller, RC Boucher, JL Schmitz, FA Askin, LR Scanga
medRxiv 2022.02.01.22270179; doi: https://doi.org/10.1101/2022.02.01.22270179
The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies
JD Ward, C Cornaby, T Kato, RC Gilmore, D Bunch, MB Miller, RC Boucher, JL Schmitz, FA Askin, LR Scanga
medRxiv 2022.02.01.22270179; doi: https://doi.org/10.1101/2022.02.01.22270179
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2806)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12492)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4360)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2809)
- Health Policy (1041)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (458)
- Neurology (4127)
- Nursing (219)
- Nutrition (612)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (478)
- Public and Global Health (6719)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)